PTC Therapeutics, Inc.
PTCT
$73.46
-$1.56-2.08%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -186.73M | 682.64M | 751.72M | 629.17M | 594.84M |
| Total Depreciation and Amortization | 47.01M | 38.82M | 32.68M | 28.05M | 27.49M |
| Total Amortization of Deferred Charges | 1.23M | 1.22M | 1.21M | 1.21M | 1.20M |
| Total Other Non-Cash Items | 41.73M | 41.08M | 36.95M | 58.73M | 74.97M |
| Change in Net Operating Assets | -121.18M | -52.56M | -107.10M | -12.39M | -6.85M |
| Cash from Operations | -217.95M | 711.20M | 715.47M | 704.77M | 691.65M |
| Capital Expenditure | -8.33M | -8.86M | -10.25M | -7.33M | 1.36M |
| Sale of Property, Plant, and Equipment | 0.00 | 70.00K | 70.00K | 88.00K | 28.13M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -763.03M | -853.19M | -618.10M | -374.09M | -54.73M |
| Cash from Investing | -771.36M | -861.98M | -628.28M | -381.33M | -25.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.61M | -1.61M | -1.61M | 0.00 | 0.00 |
| Issuance of Common Stock | 89.70M | 99.05M | 63.01M | 46.76M | 47.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 240.00M | 233.66M | -6.34M | -24.54M | 217.25M |
| Cash from Financing | 328.09M | 331.09M | 55.06M | 22.22M | 264.74M |
| Foreign Exchange rate Adjustments | 15.80M | 22.71M | 4.26M | 18.87M | 95.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -645.43M | 203.02M | 146.51M | 364.53M | 931.24M |